Filter
4530
Filtered Results: 4530
Text search:
drug
policy
Featured
Recommendations
370
New Publications
1260
Language
Document type
No document type
2860
Studies & Reports
663
Guidelines
507
Manuals
175
Strategic & Response Plan
150
Fact sheets
56
Training Material
45
Situation Updates
45
Infographics
11
Resource Platforms
8
Online Courses
5
Brochures
4
App
1
Countries / Regions
India
216
Kenya
155
Global
130
Uganda
115
South Africa
112
Western and Central Europe
108
Ethiopia
105
Nigeria
104
Nepal
92
Liberia
82
Malawi
79
Sierra Leone
78
Zambia
75
Tanzania
74
Myanmar / Burma
72
Ghana
68
Africa
64
Bangladesh
61
Latin America and the Carribbean
61
Eastern Europe
59
Ukraine
54
Rwanda
52
Namibia
48
Zimbabwe
41
Asia
40
Philippines
36
Cambodia
35
Lesotho
35
South–East Asia Region
35
Russia
33
Indonesia
32
Botswana
28
Eswatini/ Swaziland
22
Congo, Democratic Republic of
21
Mozambique
21
Senegal
20
Syria
19
Burkina Faso
18
Brazil
15
East and Southern Africa
15
West and Central Africa
13
Colombia
12
Middle East and North Africa
12
Venezuela
12
Cameroon
11
Haiti
11
Pakistan
11
South Sudan
11
Eastern Europe and Central Asia
11
Guinea
10
Germany
10
Thailand
10
Albania
10
Tajikistan
10
Georgia
10
Sudan
9
USA
7
Afghanistan
7
Moldova
7
Vietnam
7
China
6
Benin
6
North Macedonia
6
Yemen
6
Paraguay
6
Armenia
6
Laos
6
Peru
5
Mexico
5
Sri Lanka
5
Western Pacific Region
5
Somalia
4
Iraq
4
Jordan
4
Central African Republic
4
Argentina
4
El Salvador
4
Libya
4
Bhutan
4
United Kingdom
4
Lebanon
3
Turkey
3
Fiji
3
Palestine
3
Southern Africa
3
Timor Leste/ East Timor
3
Estonia
3
Iran
3
Kyrgyzstan
3
North America
3
Jamaica
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Serbia
2
Hungary
2
Bolivia
2
Chile
2
Poland
2
Canada
2
Romania
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Egypt
1
Gambia
1
Ireland
1
Switzerland
1
Greece
1
Angola
1
Madagascar
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1828
Clinical Guidelines
373
Public Health
230
Women & Child Health
170
Key Resources
89
Pharmacy & Technologies
51
Capacity Building
49
Toolboxes
HIV
598
TB
504
Mental Health
413
AMR
246
COVID-19
168
Pharmacy
138
NTDs
92
NCDs
87
Caregiver
79
Planetary Health
67
Rapid Response
60
Ebola
59
Global Health Education
55
Disability
53
Refugee
51
Conflict
46
Health Financing Toolbox
31
Polio
23
Natural Hazards
16
Specific Hazards
13
Cholera
9
Social Ethics
9
Zika
6
Health Financing
1
As a lower-middle-income country (LMIC), South Africa (SA) bears
the burden of maternal and neonatal mortality similar to other sub-
Saharan African countries. According to the Saving Mothers Report
2017/19, there has been a progressive and sustained reduction
in institutional maternal mortality...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
The Government of Kenya, through the Ministry of Health, has the
constitutional obligation to provide the highest level of health care for its
citizens. The Ministry of Health’s review of the 2015 Policy document
on infection prevention and con...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial ... resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i) improve the detection of resistance to ensure a timely response; ii) delay the emergence of resistance to artemisinin and artemisinin-based combination therapy (ACT) partner drugs; and iii) limit the selection and spread of resistant parasites where resistance has been confirmed.
WHO Team
Global Malaria Programme
Editors
World Health Organization
Number of pages
87
Reference numbers
ISBN: 978 92 4 006026 5
Copyright
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... to ensure complete cure. However, resistance to antimalarial drugs, where parasites survive standard doses, threatens malaria control.
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients w...
The COVID-19 pandemic is having a major impact on the mental health of populations in the Americas. Studies
show high rates of depression and anxiety, among other psychological symptoms, particularly among women, young
people, those with pre-existing mental health conditions, health workers, and p...
Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
Bangladesh Health Systems in Transition
